Skip to main

Corporate Partnership at AST Meetings

Unlocking Opportunities to Engage with Members

Discover exclusive opportunities to elevate your brand's presence and impact at AST meetings and events. As a corporate partner, you gain access to a diverse audience of transplantation professionals, researchers, and advocates. Showcase your commitment to innovation and patient care while networking with industry leaders. Join us in shaping the future of transplantation through strategic partnerships.

View 2026 ATC + Fellows Prospectus
View 2026 Annual Prospectus

Circle of Excellence

The AST’s Living Donor Circle of Excellence is a recognition program for companies which currently have or implement new HR policies supporting the lost wages of living donors after surgery. To find out more about becoming a member, click the link below.

Learn More

Fellows Symposium on Transplantation

Position your brand as a leader in transplant innovation when you partner with AST on our prestigious meeting for medical fellows, residents, and trainees, taking place September 25-27, 2026. Opportunities include exhibiting, branding, and medical education grants.

View 2026 Fellows Prospectus

Cutting Edge of Transplantation (CEoT)

Join transplant professionals from all disciplines and career stages February 25-27, 2027, to network, learn, and engage with the latest advancements shaping the future of transplant science and patient care. Opportunities include exhibiting and branding, satellite symposia, and medical education grants.

2027 Prospectus Coming Soon

What's it Like to Partner with Us at Live Events?

Take Part in Creative Sponsorship Opportunities

Advance Science in Transplantation

Be Part of the Action

Join Us in Making Transplant Work Fun

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi